District of Columbia: Onglyza & Kombigly… | DrugsMonitor.com

Onglyza & Kombiglyze XR litigation in District of Columbia (DC): MDL-linked practice notes, filing-deadline context, confidential review—not legal advice.

Litigation has alleged serious injuries tied to this product or device; regulatory actions, science, and defenses vary by claim and time period. This summary is general information only., District of Columbia